BioRestorative Therapies, Inc. Share Price Other OTC
Stocks
BRTX
US0906554086
Biotechnology & Medical Research
| Market Cap | 29.68L 26.19L 24.78L 22.48L 42.14L 28Cr 42.56L 2.97Cr 1.15Cr 15Cr 1.11Cr 1.09Cr 47Cr | P/E 2026 * |
-0.24x | P/E 2027 * | -0.29x |
|---|---|---|---|---|---|
| Enterprise Value | 29.68L 26.19L 24.78L 22.48L 42.14L 28Cr 42.56L 2.97Cr 1.15Cr 15Cr 1.11Cr 1.09Cr 47Cr | EV / Sales 2026 * |
2.11x | EV / Sales 2027 * | 1.28x |
| Free-Float |
90.44% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioRestorative Therapies, Inc.
| 1 day | +1.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Mika Grasso
CEO | Chief Executive Officer | 28 | 27/08/2026 |
Anna Skowron
DFI | Director of Finance/CFO | 38 | 27/08/2026 |
Rory Rumore
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Mika Grasso
BRD | Director/Board Member | 28 | 12/06/2026 |
Jay Dhaliwal
BRD | Director/Board Member | 37 | 12/06/2026 |
Esha Randhawa
BRD | Director/Board Member | - | 13/07/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.08% | +0.25% | - | - | 29.43L | |
| -0.70% | -4.28% | +52.62% | +86.42% | 7.18TCr | |
| +0.45% | -0.82% | +38.81% | +84.19% | 6.01TCr | |
| +3.64% | +4.92% | +35.19% | +24.63% | 2.79TCr | |
| -1.73% | -4.30% | -18.37% | +357.94% | 2.57TCr | |
| -0.51% | -2.28% | +0.48% | -9.27% | 2.49TCr | |
| +0.65% | +1.67% | +26.47% | -7.62% | 2.09TCr | |
| +3.46% | +3.02% | +158.90% | +337.81% | 1.5TCr | |
| +0.48% | +0.86% | +44.56% | +168.42% | 1.45TCr | |
| +4.65% | +2.40% | -3.77% | +529.26% | 1.39TCr | |
| Average | +1.13% | -1.38% | +37.21% | +174.64% | 3.05TCr | |
| Weighted average by Cap. | +0.56% | -1.84% | +37.02% | +129.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.05L 12.4L 11.73L 10.64L 19.95L 13Cr 20.14L 1.41Cr 54.24L 6.88Cr 52.76L 51.61L 22Cr | 23.12L 20.41L 19.31L 17.51L 32.83L 22Cr 33.15L 2.32Cr 89.27L 11Cr 86.83L 84.95L 36Cr |
| Net income | -1.35Cr -1.19Cr -1.13Cr -1.02Cr -1.92Cr -129.77Cr -1.94Cr -14Cr -5.22Cr -66Cr -5.08Cr -4.97Cr -213.24Cr | -1.56Cr -1.37Cr -1.3Cr -1.18Cr -2.21Cr -149.29Cr -2.23Cr -16Cr -6.01Cr -76Cr -5.84Cr -5.72Cr -245.33Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
